Cargando…
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
BACKGROUND: SARS-CoV-2 is a novel coronavirus first recognized in late December 2019 that causes coronavirus disease 19 (COVID-19). Due to the highly contagious nature of SARS-CoV-2, it has developed into a global pandemic in just a few months. Antibody testing is an effective method to supplement t...
Autores principales: | Qin, Xuzhen, Shen, Jun, Dai, Erhei, Li, Haolong, Tang, Guodong, Zhang, Lixia, Hou, Xin, Lu, Minya, Wu, Xian, Duan, Simeng, Zhang, Jingjia, Tsoi, Man-Fung, Jiang, Ping, Li, Yongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887538/ https://www.ncbi.nlm.nih.gov/pubmed/33596826 http://dx.doi.org/10.1186/s12865-021-00404-0 |
Ejemplares similares
-
Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021) -
The seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic stroke
por: Roham, Maryam, et al.
Publicado: (2016) -
Kinetics of IgM and IgG antibodies after scrub typhus infection and the clinical implications
por: Varghese, George M., et al.
Publicado: (2018) -
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19
patients
por: Sun, Baoqing, et al.
Publicado: (2020) -
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)